Impact of Systematic Assessment and Monitoring Services (SAMS) on Health Outcomes in COPD Patients - SAMS

Sam Johnson Udaya Chander J0 个研究点目标入组 300 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Age greater than or equal to 40.
•2. Diagnosed to have COPD graded according to Global Initiative for Obstructive Lung Disease (GOLD) as mild to very severe.
•3. Receiving ongoing COPD medications.
•4. Patient with or without smoking history.
•5. Competent enough to consider informed consent.
•6. All patients who are interested in quitting smoking.

•1.Patients with history of asthma, allergic rhinitis, lung operation, or other respiratory disease.
•2. Patients with history of serious concomitant diseases such as heart failure, liver, or renal failure.
•3. Severe mobility problems or terminal illness.
•4. Mental disability.
•5. Active alcohol or drug abuse.
•6. Inability to understand the program.
•7. Inability of informal care at home.
•8. Unavailability of telephone system at home

发起方

Sam Johnson Udaya Chander J